Patent · US Active

Vascular leakage inhibitor

US9353144B2 · kind B2 · utility

0Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 28, 2012
Grant dateMay 31, 2016
Priority date
Expiry dateDec 28, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J43/003
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to a novel vascular leakage inhibitor. The novel vascular leakage inhibitor of the present invention inhibits the apoptosis of vascular endothelial cells, inhibits the formation of actin stress fibers induced by VEGF, and enhances the cortical actin ring structure, thereby inhibiting vascular leakage. Accordingly, the vascular leakage inhibitor of the present invention can prevent or treat various diseases caused by vascular leakage. Since the vascular leakage inhibitor of the present invention is synthesized from commercially available or easily synthesizable pregnenolones, it has remarkably superior feasibility of commercial synthesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.